| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Maxillofacial Unit/Oncology. King’s College Hospital, London, SE5 8RX [M. P., S. P., E. P., G. G. E., J. D. L.], and Royal Marsden NHS Trust, London, SW3 6JJ [R. P. A.], United Kingdom
Distinguishing true precursor lesions on the basis of clinical or histological features alone is unreliable but is important so that appropriate intervention can be instigated. Preliminary studies have shown that a microsatellite assay may provide important new prognostic information. To build on these observations, we have performed a case-control study to establish whether we can be confident about incorporating this new information into clinical practice. We have determined the frequency of allelic imbalance (AI) within key chromosomal regions, by matching 39 cases with dysplastic oral lesions that developed a tumor on the same side of the mouth, for as many variables as possible, with controls presenting with similar lesions that did not progress to malignancy when followed for the same period. Our findings confirm that the group that developed tumor had precursor lesions that harbor AI at more loci (P = 0.002). However, no consistent patterns of AI were associated with the three grades of dysplasia: mild, moderate, and severe. One-third of the tumors developed at the same site as the dysplastic lesion and two-thirds at a different site, which revealed that the presence of these aberrations in a dysplastic lesion provided information about the risk of malignant change within a larger field. This suggests that the process of field cancerization is more widespread than previously recognized. On the basis of these findings, we advocate complete excision of all suspicious areas that show AI at two or more key loci, regardless of the degree of dysplasia. However, because the remaining mucosa is also "at risk," these cases should also be targeted to receive dietary advice and chemoprevention, to minimize their risk of tumor formation at a distant site.
This article has been cited by other articles:
|
|
 |
|
  G. J. Kelloff, C. C. Sigman, and C. H. Contag Early Detection of Oral Neoplasia: Watching with New Eyes Cancer Prevention Research, May 1, 2009; 2(5): 405 - 408. [Full Text] [PDF]
|
|
|
|
|
|
J. F. Bremmer, A. P. Graveland, A. Brink, B. J.M. Braakhuis, D. J. Kuik, C. R. Leemans, E. Bloemena, I. van der Waal, and R. H. Brakenhoff Screening for Oral Precancer with Noninvasive Genetic Cytology Cancer Prevention Research, February 1, 2009; 2(2): 128 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. F.L. Tsui, M. P. Rosin, L. Zhang, R. T. Ng, and W. L. Lam Multiple Aberrations of Chromosome 3p Detected in Oral Premalignant Lesions Cancer Prevention Research, November 1, 2008; 1(6): 424 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kawaguchi, A. K. El-Naggar, V. Papadimitrakopoulou, H. Ren, Y.-H. Fan, L. Feng, J. J. Lee, E. Kim, W. K. Hong, S. M. Lippman, et al. Podoplanin: A Novel Marker for Oral Cancer Risk in Patients With Oral Premalignancy J. Clin. Oncol., January 20, 2008; 26(3): 354 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. N. William Jr. and V. A. Papadimitrakopoulou Identification of High-risk Cohorts for Head and Neck Cancer Prevention Based on Tissue Markers LOH and cyclin D1 ASCO Educational Book, January 1, 2008; 2008(1): 66 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Huang, S. Pateromichelakis, A. Hills, M. Sherriff, A. Lyons, J. Langdon, E. Odell, P. Morgan, J. Harrison, and M. Partridge p53 Mutations in Deep Tissues Are More Strongly Associated with Recurrence than Mutation-Positive Mucosal Margins Clin. Cancer Res., October 15, 2007; 13(20): 6099 - 6106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Gaballah, A. Hills, D. Curiel, G. Hallden, P. Harrison, and M. Partridge Lysis of Dysplastic but not Normal Oral Keratinocytes and Tissue-Engineered Epithelia with Conditionally Replicating Adenoviruses Cancer Res., August 1, 2007; 67(15): 7284 - 7294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Poh, L. Zhang, D. W. Anderson, J. S. Durham, P. M. Williams, R. W. Priddy, K. W. Berean, S. Ng, O. L. Tseng, C. MacAulay, et al. Fluorescence Visualization Detection of Field Alterations in Tumor Margins of Oral Cancer Patients. Clin. Cancer Res., November 15, 2006; 12(22): 6716 - 6722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. Neville, A. C. Chi, and M. Jeter A red lesion on the palate. J Am Dent Assoc, November 1, 2006; 137(11): 1537 - 1538. [Full Text] [PDF]
|
|
|
|
|
|
G. J. Kelloff, S. M. Lippman, A. J. Dannenberg, C. C. Sigman, H. L. Pearce, B. J. Reid, E. Szabo, V. C. Jordan, M. R. Spitz, G. B. Mills, et al. Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward Clin. Cancer Res., June 15, 2006; 12(12): 3661 - 3697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lippman and J. J. Lee Reducing the "Risk" of Chemoprevention: Defining and Targeting High Risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture. Cancer Res., March 15, 2006; 66(6): 2893 - 2903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, M. Williams, C. F. Poh, D. Laronde, J. B. Epstein, S. Durham, H. Nakamura, K. Berean, A. Hovan, N. D. Le, et al. Toluidine Blue Staining Identifies High-Risk Primary Oral Premalignant Lesions with Poor Outcome Cancer Res., September 1, 2005; 65(17): 8017 - 8021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lippman, J. Sudbo, and W. K. Hong Oral Cancer Prevention and the Evolution of Molecular-Targeted Drug Development J. Clin. Oncol., January 10, 2005; 23(2): 346 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Ellsworth, R. E. Ellsworth, B. Love, B. Deyarmin, S. M. Lubert, V. Mittal, J. A. Hooke, and C. D. Shriver Outer Breast Quadrants Demonstrate Increased Levels of Genomic Instability Ann. Surg. Oncol., September 1, 2004; 11(9): 861 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. M. Braakhuis, P. J. F. Snijders, W.-J. H. Keune, C. J. L. M. Meijer, H. J. Ruijter-Schippers, C. R. Leemans, and R. H. Brakenhoff Genetic Patterns in Head and Neck Cancers That Contain or Lack Transcriptionally Active Human Papillomavirus J Natl Cancer Inst, July 7, 2004; 96(13): 998 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Tabor, R. H. Brakenhoff, H. J. Ruijter-Schippers, J. A. Kummer, C. R. Leemans, and B. J. M. Braakhuis Genetically Altered Fields as Origin of Locally Recurrent Head and Neck Cancer: A Retrospective Study Clin. Cancer Res., June 1, 2004; 10(11): 3607 - 3613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sudbo, S. M. Lippman, J. J. Lee, L. Mao, W. Kildal, A. Sudbo, S. Sagen, M. Bryne, A. El-Naggar, B. Risberg, et al. The Influence of Resection and Aneuploidy on Mortality in Oral Leukoplakia N. Engl. J. Med., April 1, 2004; 350(14): 1405 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q.-T. Le and A. J. Giaccia Therapeutic Exploitation of the Physiological and Molecular Genetic Alterations in Head and Neck Cancer Clin. Cancer Res., October 1, 2003; 9(12): 4287 - 4295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Ha and J. A. Califano THE MOLECULAR BIOLOGY OF MUCOSAL FIELD CANCERIZATION OF THE HEAD AND NECK Critical Reviews in Oral Biology & Medicine, September 1, 2003; 14(5): 363 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. M. Braakhuis, M. P. Tabor, J. A. Kummer, C. R. Leemans, and R. H. Brakenhoff A Genetic Explanation of Slaughter's Concept of Field Cancerization: Evidence and Clinical Implications Cancer Res., April 15, 2003; 63(8): 1727 - 1730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Reibel PROGNOSIS OF ORAL PRE-MALIGNANT LESIONS: SIGNIFICANCE OF CLINICAL, HISTOPATHOLOGICAL, AND MOLECULAR BIOLOGICAL CHARACTERISTICS Critical Reviews in Oral Biology & Medicine, January 1, 2003; 14(1): 47 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Rosin, W. L. Lam, C. Poh, N. D. Le, R. J. Li, T. Zeng, R. Priddy, and L. Zhang 3p14 and 9p21 Loss Is a Simple Tool for Predicting Second Oral Malignancy at Previously Treated Oral Cancer Sites Cancer Res., November 15, 2002; 62(22): 6447 - 6450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Forastiere, W. Koch, A. Trotti, and D. Sidransky Head and Neck Cancer N. Engl. J. Med., December 27, 2001; 345(26): 1890 - 1900. [Full Text] [PDF]
|
|
|
|
|
|
M. Partridge, S. Pateromichelakis, E. Phillips, G. Emilion, and J. Langdon Profiling Clonality and Progression in Multiple Premalignant and Malignant Oral Lesions Identifies a Subgroup of Cases with a Distinct Presentation of Squamous Cell Carcinoma Clin. Cancer Res., July 1, 2001; 7(7): 1860 - 1866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Guo, K. Yamaguchi, M. Sanchez-Cespedes, W. H. Westra, W. M. Koch, and D. Sidransky Allelic Losses in OraTest-directed Biopsies of Patients with Prior Upper Aerodigestive Tract Malignancy Clin. Cancer Res., July 1, 2001; 7(7): 1963 - 1968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lippman and W. K. Hong Molecular Markers of the Risk of Oral Cancer N. Engl. J. Med., April 26, 2001; 344(17): 1323 - 1326. [Full Text] [PDF]
|
|
|
|
|
|
W. K. Hong, M. R. Spitz, and S. M. Lippman Cancer Chemoprevention in the 21st Century: Genetics, Risk Modeling, and Molecular Targets J. Clin. Oncol., November 1, 2000; 18(90001): 9s - 18. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
